Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) Net Margin (2017 - 2025)

Organogenesis Holdings (ORGO) has 9 years of Net Margin data on record, last reported at 15.57% in Q4 2025.

  • For Q4 2025, Net Margin rose 1093.0% year-over-year to 15.57%; the TTM value through Dec 2025 reached 3.55%, up 374.0%, while the annual FY2025 figure was 3.55%, 374.0% up from the prior year.
  • Net Margin reached 15.57% in Q4 2025 per ORGO's latest filing, up from 12.39% in the prior quarter.
  • Across five years, Net Margin topped out at 16.79% in Q2 2021 and bottomed at 24.91% in Q1 2025.
  • Average Net Margin over 5 years is 3.14%, with a median of 4.58% recorded in 2024.
  • Peak YoY movement for Net Margin: skyrocketed 3612bps in 2021, then plummeted -2300bps in 2025.
  • A 5-year view of Net Margin shows it stood at 14.88% in 2021, then crashed by -56bps to 6.48% in 2022, then crashed by -78bps to 1.45% in 2023, then skyrocketed by 220bps to 4.64% in 2024, then surged by 236bps to 15.57% in 2025.
  • Per Business Quant database, its latest 3 readings for Net Margin were 15.57% in Q4 2025, 12.39% in Q3 2025, and 12.08% in Q2 2025.